miR-155: On the Crosstalk Between Inflammation and Cancer

REFERENCES

• Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350–355
   PubMed Web of Science ®Google Scholar
• Bartel D. P. MicroRNAs: Genomics, biogenesis, mechanism and function. Cell 2003; 116: 281–297
   Google Scholar
• Calin G. A., Croce C. M. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857–866
   PubMed Web of Science ®Google Scholar
• Tili E., Michaille J-J., Gandhi V., Plunkett W., Sampath D., Calin G. A. miRNAs and their potential for use against cancer and other diseases. Future Oncol 2007; 3: 521–537
   PubMedGoogle Scholar
• Tili E., Michaille J-J., Calin G. A. Expression and function of micro-RNAs in immune cells during normal or disease state. Int J Med Sci 2008; 5: 73–79
   PubMedGoogle Scholar
• Tili E., Michaille J-J., Costinean S., Croce C. M. MicroRNAs, the immune system and rheumatic disease. Nat Clin Pract Rheumatol 2008; 4: 534–541
   Google Scholar
• Volinia S., Calin G. A., Liu C. G., Ambs S., Cimmino A., Petrocca F., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006; 103: 2257–2261
   PubMed Web of Science ®Google Scholar
• Clurman B. E., Hayward W. S. Multiple proto-oncogene activations in avian leukosis virus-induced lymphomas: Evidence for stage-specific events. Mol Cell Biol 1989; 9: 2657–2664
   PubMed Web of Science ®Google Scholar
• Tam W., Ben-Yehuda D., Hayward W. S. BIC, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Mol Cell Biol 1997; 17: 1490–1502
   PubMed Web of Science ®Google Scholar
• Tam W., Dahlberg J. E. miR-155/BIC as an oncogenic microRNA. Genes Chromosomes Cancer 2006; 45: 211–212
   PubMed Web of Science ®Google Scholar
• Eis P. S., Tam W., Sun L., Chadburn A., Li Z., Gomez M. F., et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A 2005; 102: 3627–3632
   PubMed Web of Science ®Google Scholar
• Kluiver J., van den Berg A., de Jong D., Blokzijl T., Harms G., Bouwman E., et al. Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma. Oncogene 2007; 26: 3769–3776
   PubMed Web of Science ®Google Scholar
• van den Berg Kroesen B. J., Kooistra K., de Jong D., Briggs J., Blokzijl T., et al. High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes Cancer 2003; 37: 20–28
   Google Scholar
• Kluiver J., Poppema S., de Jong D., Blokzijl T., Harms G., Jacobs S., et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 2005; 207: 243–249
   PubMed Web of Science ®Google Scholar
• Kluiver J., Haralambieva E., de Jong D., Blokzijl T., Jacobs S., Kroesen B. J., et al. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer 2006; 45: 147–153
   PubMed Web of Science ®Google Scholar
• Calin G. A., Ferracin M., Cimmino A., Di Leva G., Shimizu M., Wojcik S. E., et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005; 353: 1793–1801
   PubMed Web of Science ®Google Scholar
• Wang M., Tan L. P., Dijkstra M. K., van Lom K., Robertus J. L., Harms G., et al. miRNA analysis in B-cell chronic lymphocytic leukaemia: Proliferation centres characterized by low miR-150 and high BIC/miR-155 expression. J Pathol 2008; 215: 13–20
   PubMed Web of Science ®Google Scholar
• Lawrie C. H., Soneji S., Marafioti T., Cooper C. D., Palazzo S., Paterson J. C., et al. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer 2007; 121: 1156–61
   PubMed Web of Science ®Google Scholar
• O'Connell R. M., Rao D. S., Chaudhuri A. A., Boldin M. P., Taganov K. D., Nicoll J., et al. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 2008; 205: 585–594
   PubMed Web of Science ®Google Scholar
• Costinean S., Zanesi N., Pekarsky Y., Tili E., Volinia S., Heerema N., et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A 2006; 103: 7024–7029
   PubMed Web of Science ®Google Scholar
• Tam W., Hughes S. H., Hayward W. S., Besmer P. Avian BIC, a gene isolated from a common retroviral site in avian leukosis virus-induced lymphomas that encodes a noncoding RNA, cooperates with c-myc in lymphomagenesis and erythroleukemogenesis. J Virol 2002; 76: 4275–4286
   PubMed Web of Science ®Google Scholar
• Ovcharenko D., Kelnar K., Johnson C., Leng N., Brown D. Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. Cancer Res 2007; 67: 10782–10788
   PubMed Web of Science ®Google Scholar
• Tili E., Michaille J-J., Cimino A., Costinean S., Dumitru C. D., Adair B., et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 2007; 179: 5082–5089
   PubMed Web of Science ®Google Scholar
• Gironella M., Seux M., Xie M. J., Cano C., Tomasini R., Gommeaux J., et al. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci U S A 2007; 104: 16170–16175
   PubMed Web of Science ®Google Scholar
• Georgantas R. W., 3rd, Hildreth R., Morisot S., Alder J., Liu C. G., Heimfeld S., et al. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: A circuit diagram of differentiation control. Proc Natl Acad Sci U S A 2007; 104: 2750–2755
   PubMed Web of Science ®Google Scholar
• Romania P., Luli V., Pelosi E., Biffoni M., Peschle C., Marziali G. MicroRNA-155 modulates megakaryopoiesis at progenitor and precursor level by targeting ETS-1 and Meis1 transcription factors. BJH 2008; 143: 570–580
   PubMed Web of Science ®Google Scholar
• Thai T. H., Calado D. P., Casola S., Ansel K. M., Xiao C., Xue Y., et al. Regulation of the germinal center response by microRNA-155. Science 2007; 316: 604–608
   PubMed Web of Science ®Google Scholar
• Rodriguez A., Vigorito E., Clare S., Warren M. V., Couttet P., Soond D. R., et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007; 316: 608–611
   PubMed Web of Science ®Google Scholar
• Vigorito E., Perks K. L., Abreu-Goodger C., Bunting S., Xiang Z., Kohlhaas S., et al. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 2007; 27: 847–859
   PubMed Web of Science ®Google Scholar
• Klein U., Dalla-Favera R. Germinal centres: Role in B-cell physiology and malignancy. Nat Rev Immunol 2008; 8: 22–33
   PubMed Web of Science ®Google Scholar
• Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000; 102: 553–563
   PubMed Web of Science ®Google Scholar
• Dorsett Y., Robbiani D. F., Jankovic M., Reina-San-Martin B., Eisenreich T. R., Nussenzweig M. C. A role for AID in chromosome translocations between c-myc and the IgH variable region. J Exp Med 2007; 204: 2225–2232
   PubMedGoogle Scholar
• Dorsett Y., McBride K. M., Jankovic M., Gazumyan A., Thai T. H., Robbiani D. F., et al. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 2008; 28: 630–638
   PubMed Web of Science ®Google Scholar
• Teng G., Hakimpour P., Landgraf P., Rice A., Tuschl T., Casellas R., et al. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 2008; 28: 621–629
   PubMed Web of Science ®Google Scholar
• Yin Q., Wang X., McBride J., Fewell C., Flemington E. B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element. J Biol Chem 2008; 283: 2654–2662
   PubMed Web of Science ®Google Scholar
• O'Connell R. M., Taganov K. D., Boldin M. P., Cheng G., Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 2007; 104: 1604–1609
   PubMed Web of Science ®Google Scholar
• Haasch D., Chen Y. W., Reilly R. M., Chiou X. G., Koterski S., Smith M. L., et al. T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene. BIC Cell Immunol 2002; 217: 78–86
   PubMed Web of Science ®Google Scholar
• Cobb B. S., Hertweck A., Smith J., O'Connor E., Graf D., Cook T., et al. A role for Dicer in immune regulation. J Exp Med 2006; 203: 2519–2527
   PubMed Web of Science ®Google Scholar
• Marson A., Kretschmer K., Frampton G. M., Jacobsen E. S., Polansky J. K., MacIsaac K. D., et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 2007; 445: 931–935
   PubMed Web of Science ®Google Scholar
• Zheng Y., Rudensky A. Y. Foxp3 in control of the regulatory T cell lineage. Nat Immunol 2007; 8: 457–462
   PubMed Web of Science ®Google Scholar
• Gavin M. A., Rasmussen J. P., Fontenot J. D., Vasta V., Manganiello V. C., Beavo J. A., et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007; 445: 771–775
   PubMed Web of Science ®Google Scholar
• Lu L., Thai T., Calado D., Chaudhry A., Kubo M., Tanaka K., et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 2009; 30: 80–91
   PubMed Web of Science ®Google Scholar
• Gottwein E., Mukherjee N., Sachse C., Frenzel C., Majoros W. H., Chi J. T., et al. A viral microRNA functions as an orthologue of cellular miR-155. Nature 2007; 450: 1096–1099
   PubMed Web of Science ®Google Scholar
• Skalsky R. L., Samols M. A., Plaisance K. B., Boss I. W., Riva A., Lopez M. C., et al. Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol 2007; 81: 12836–12845
   PubMed Web of Science ®Google Scholar
• Morgan R., Anderson A., Bernberg E., Kamboj S., Huang E., Lagasse G., et al. Sequence conservation and differential expression of Marek's disease virus microRNAs. J Virol 2008; 82: 12213–12220
   PubMed Web of Science ®Google Scholar
• Zhao Y., Yao Y., Xu H., Lambeth L., Smith L. P., Kgosana L., et al. A functional microRNA-155 ortholog encoded by the oncogenic Marek's disease virus. J Virol 2009; 83: 489–492
   PubMed Web of Science ®Google Scholar
• Pichler K., Schneider G., Grassmann R. MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1 transformed T lymphocytes. Retrovirology 2008; 5: 1742–1745
   Google Scholar
• Lu F., Weidmer A., Liu C. G., Volinia S., Croce C. M., Lieberman P. M. Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. J Virol 2008; 82: 10436–10443
   PubMed Web of Science ®Google Scholar
• Yin Q., McBride J., Fewell C., Lacey M., Wang X., Lin Z., et al. MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J Virol 2008; 82: 5295–5306
   PubMedGoogle Scholar
• Rahadiani N., Takakuwa T., Tresnasari K., Morii E., Aozasa K. Latent membrane protein-1 of Epstein-Barr virus induces the expression of B-cell integration cluster, a precursor form of microRNA-155, in B lymphoma cell lines. Biochem Biophys Res Commun 2008; 377: 579–583
   Google Scholar
• Gatto G., Rossi A., Rossi D., Kroening S., Bonatti S., Mallardo M. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway. Nucleic Acids Res 2008; 36: 6608–6619
   PubMed Web of Science ®Google Scholar
• Rai D., Karanti S., Jung I., Dahia P. L., Aguiar R. C. Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. Cancer Genet Cytogenet 2008; 181: 8–15
   PubMed Web of Science ®Google Scholar
• Murphy D., Junttila M., Pouyet L., Karnezis A., Shchors K., Bui D., et al. Distinct thresholds govern Myc's biological output in vivo. Cancer Cell 2009; 14: 447–457
   Google Scholar
• Tran P. T., Fan A. C., Bendapudi P. K., Koh S., Komatsubara K., Chen J., et al. Combined inactivation of Myc and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas. PLoS ONE 2008; 3: e2125
   Web of Science ®Google Scholar
• Costinean S., Sandhu S., Pedersen I., Tili E., Trotta R., Perrotti D., et al. Ship and C/ebpβ are targeted by miR-155 in B cells of Eμ -miR155 transgenic mice. Blood, in press
   Google Scholar
• Kong W., Yang H., He L., Zhao J. J., Coppola D., Dalton W. S., et al. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol 2008; 28: 6773–6784
   PubMed Web of Science ®Google Scholar
• Martin M. M., Lee E. J., Buckenberger J. A., Schmittgen T. D., Elton T. S. MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J Biol Chem 2006; 281: 18277–18284
   PubMed Web of Science ®Google Scholar